GSK3B and neoplasm: By binding to its ligand, LOX-1 can activate NOX/MAPKs/NF-κB or PI3K/Akt/GSK3β signaling pathways, regulate the expression of genes such as inflammation, hypoxia, and oxidative stress, and then promote tumor growth, migration, and invasion by effective new blood vessels [7–9].